CollPlant Biotechnologies (CLGN) Revenue (2017 - 2025)
CollPlant Biotechnologies (CLGN) reported Revenue of $60000.0 for Q4 2025, down 63.41% on a YoY basis from $164000.0 in Q4 2024, and down 22.08% quarter-over-quarter from $77000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Revenue (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Revenue for 9 years, with the latest figure at $60000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 63.41% year-over-year to $60000.0; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 360.39% YoY), and the FY2025 full-year result was $2.4 million, up 360.39% from the prior year.
- Revenue for Q4 2025 stood at $60000.0, down from $77000.0 in the prior quarter.
- The five-year high for Revenue was $43.0 billion in Q3 2023, with the low at $4000.0 in Q3 2024.
- Historically, Revenue has averaged $2.3 billion across 5 years, with a median of $179000.0 in 2025.
- Annual changes were most pronounced in 2023 — Revenue soared 39449441.28% — and 2024, when it sank 100.0%.
- CollPlant Biotechnologies' Revenue stood at $310000.0 in 2021, then slumped by 81.29% to $58000.0 in 2022, then jumped by 415.52% to $299000.0 in 2023, then sank by 45.15% to $164000.0 in 2024, then slumped by 63.41% to $60000.0 in 2025.
- The last three Revenue figures came in at $60000.0 (Q4 2025), $77000.0 (Q3 2025), and $179000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 299,000.00 |
| Sep 30, 2023 | 43.00 Bn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Dec 31, 2021 | 310,000.00 |
| Sep 30, 2021 | 140,000.00 |
| Jun 30, 2021 | 691,000.00 |
| Mar 31, 2021 | 14.50 Mn |
| Dec 31, 2020 | 6.13 Mn |